Spots Global Cancer Trial Database for A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer
Official Title: A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants With Advanced Gastric Cancer (FRACTION-Gastric Cancer)
Study ID: NCT02935634
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the preliminary efficacy, safety, and tolerability of Nivolumab in combination with Ipilimumab or other treatment therapies in participants with advanced gastric cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mayo Clinic Arizona, Phoenix, Arizona, United States
Local Institution - 0020, Duarte, California, United States
University Of Colorado, Aurora, Colorado, United States
Local Institution - 0032, New Haven, Connecticut, United States
Local Institution - 0036, Washington, District of Columbia, United States
UF Health Medical Oncology - Davis Cancer Pavilion, Gainesville, Florida, United States
Local Institution - 0038, Jacksonville, Florida, United States
Local Institution - 0006, Baltimore, Maryland, United States
Local Institution - 0017, Rochester, Minnesota, United States
Local Institution - 0003, Saint Louis, Missouri, United States
Local Institution - 0001, Hackensack, New Jersey, United States
Local Institution - 0007, New York, New York, United States
Local Institution - 0002, Portland, Oregon, United States
Local Institution - 0005, Philadelphia, Pennsylvania, United States
UPMC, Pittsburgh, Pennsylvania, United States
Local Institution - 0004, Seattle, Washington, United States
Local Institution - 0035, Westmead, New South Wales, Australia
Local Institution - 0033, Heidelberg, Victoria, Australia
Local Institution, Randwick, , Australia
Local Institution, Edmonton, Alberta, Canada
Local Institution, Vancouver, British Columbia, Canada
Local Institution, Ottawa, Ontario, Canada
Local Institution - 0025, Toronto,, Ontario, Canada
Local Institution - 0021, Toronto, Ontario, Canada
Local Institution - 0039, Heidelberg, , Germany
Local Institution - 0043, Leipzig, , Germany
Local Institution, Ramat Gan, , Israel
Local Institution, Tel Aviv, , Israel
Local Institution - 0014, Milan, Lombardia, Italy
IRCCS Istituto Nazionale Tumori Milano, Milano, , Italy
Local Institution, Amsterdam, , Netherlands
Local Institution, Utrecht, , Netherlands
Local Institution - 0050, Singapore, , Singapore
Local Institution - 0041, Chur, Graubünden (de), Switzerland
Local Institution - 0042, Zuerich, , Switzerland
Contact Details
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
